Endogenous mediators in emergency department patients with presumed sepsis: Are levels associated with progression to severe sepsis and death?
Study Objective: We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-α, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients w...
Saved in:
| Published in | Annals of emergency medicine Vol. 35; no. 1; pp. 26 - 34 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Mosby, Inc
2000
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0196-0644 1097-6760 |
| DOI | 10.1016/S0196-0644(00)70101-6 |
Cover
| Abstract | Study Objective: We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-α, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients with presumed noninfectious SIRS, whether levels are associated with septic complications, and whether there are potential relationships between mediators.
Methods: A prospective, observational tricenter study of a convenience sample of adults presenting to the emergency department meeting Bone’s criteria for SIRS (any combination of fever or hypothermia, tachycardia, tachypnea, or WBC count aberration) was performed. Mediator levels were determined and associated with deterioration to severe sepsis (hypotension, hypoperfusion, or organ dysfunction) and death in subjects admitted to the hospital with presumed sepsis.
Results: One hundred eighty subjects with SIRS were enrolled and classified into 3 groups: group 1 (SIRS, presumed infection, admitted; n=108), group 2 (SIRS, presumed infection, discharged; n=27), and group 3 (SIRS, presumed noninfectious, admitted; n=45). Group 1 TNF-α and IL-6 levels were significantly higher than those found in the other groups. NO levels for groups 1 and 2 were significantly lower than those for group 3. TNF-α and IL-6 levels were higher in the group 1 subjects who had bacteremia or progressed to severe sepsis or death. NO levels were not associated with these outcomes.
Conclusion: ED patients admitted with presumed sepsis have elevated cytokine levels compared with patients with sepsis who are discharged and with those patients with presumed noninfectious SIRS. An association appears to exist between cytokines and subsequent septic complications in these patients. The importance of these measures as clinical predictors for the presence of infection and subsequent septic complications needs to be evaluated. [Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK. Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death?
Ann Emerg Med . January 2000;35:26-34.] |
|---|---|
| AbstractList | Study Objective: We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-α, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients with presumed noninfectious SIRS, whether levels are associated with septic complications, and whether there are potential relationships between mediators.
Methods: A prospective, observational tricenter study of a convenience sample of adults presenting to the emergency department meeting Bone’s criteria for SIRS (any combination of fever or hypothermia, tachycardia, tachypnea, or WBC count aberration) was performed. Mediator levels were determined and associated with deterioration to severe sepsis (hypotension, hypoperfusion, or organ dysfunction) and death in subjects admitted to the hospital with presumed sepsis.
Results: One hundred eighty subjects with SIRS were enrolled and classified into 3 groups: group 1 (SIRS, presumed infection, admitted; n=108), group 2 (SIRS, presumed infection, discharged; n=27), and group 3 (SIRS, presumed noninfectious, admitted; n=45). Group 1 TNF-α and IL-6 levels were significantly higher than those found in the other groups. NO levels for groups 1 and 2 were significantly lower than those for group 3. TNF-α and IL-6 levels were higher in the group 1 subjects who had bacteremia or progressed to severe sepsis or death. NO levels were not associated with these outcomes.
Conclusion: ED patients admitted with presumed sepsis have elevated cytokine levels compared with patients with sepsis who are discharged and with those patients with presumed noninfectious SIRS. An association appears to exist between cytokines and subsequent septic complications in these patients. The importance of these measures as clinical predictors for the presence of infection and subsequent septic complications needs to be evaluated. [Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK. Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death?
Ann Emerg Med . January 2000;35:26-34.] We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-alpha, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients with presumed noninfectious SIRS, whether levels are associated with septic complications, and whether there are potential relationships between mediators. A prospective, observational tricenter study of a convenience sample of adults presenting to the emergency department meeting Bone's criteria for SIRS (any combination of fever or hypothermia, tachycardia, tachypnea, or WBC count aberration) was performed. Mediator levels were determined and associated with deterioration to severe sepsis (hypotension, hypoperfusion, or organ dysfunction) and death in subjects admitted to the hospital with presumed sepsis. One hundred eighty subjects with SIRS were enrolled and classified into 3 groups: group 1 (SIRS, presumed infection, admitted; n=108), group 2 (SIRS, presumed infection, discharged; n=27), and group 3 (SIRS, presumed noninfectious, admitted; n=45). Group 1 TNF-alpha and IL-6 levels were significantly higher than those found in the other groups. NO levels for groups 1 and 2 were significantly lower than those for group 3. TNF-alpha and IL-6 levels were higher in the group 1 subjects who had bacteremia or progressed to severe sepsis or death. NO levels were not associated with these outcomes. ED patients admitted with presumed sepsis have elevated cytokine levels compared with patients with sepsis who are discharged and with those patients with presumed noninfectious SIRS. An association appears to exist between cytokines and subsequent septic complications in these patients. The importance of these measures as clinical predictors for the presence of infection and subsequent septic complications needs to be evaluated. We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-alpha, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients with presumed noninfectious SIRS, whether levels are associated with septic complications, and whether there are potential relationships between mediators.STUDY OBJECTIVEWe sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-alpha, interleukin (IL) 6, and nitric oxide (NO) measured in patients with presumed sepsis (systemic inflammatory response syndrome [SIRS] and infection) are different than levels in patients with presumed noninfectious SIRS, whether levels are associated with septic complications, and whether there are potential relationships between mediators.A prospective, observational tricenter study of a convenience sample of adults presenting to the emergency department meeting Bone's criteria for SIRS (any combination of fever or hypothermia, tachycardia, tachypnea, or WBC count aberration) was performed. Mediator levels were determined and associated with deterioration to severe sepsis (hypotension, hypoperfusion, or organ dysfunction) and death in subjects admitted to the hospital with presumed sepsis.METHODSA prospective, observational tricenter study of a convenience sample of adults presenting to the emergency department meeting Bone's criteria for SIRS (any combination of fever or hypothermia, tachycardia, tachypnea, or WBC count aberration) was performed. Mediator levels were determined and associated with deterioration to severe sepsis (hypotension, hypoperfusion, or organ dysfunction) and death in subjects admitted to the hospital with presumed sepsis.One hundred eighty subjects with SIRS were enrolled and classified into 3 groups: group 1 (SIRS, presumed infection, admitted; n=108), group 2 (SIRS, presumed infection, discharged; n=27), and group 3 (SIRS, presumed noninfectious, admitted; n=45). Group 1 TNF-alpha and IL-6 levels were significantly higher than those found in the other groups. NO levels for groups 1 and 2 were significantly lower than those for group 3. TNF-alpha and IL-6 levels were higher in the group 1 subjects who had bacteremia or progressed to severe sepsis or death. NO levels were not associated with these outcomes.RESULTSOne hundred eighty subjects with SIRS were enrolled and classified into 3 groups: group 1 (SIRS, presumed infection, admitted; n=108), group 2 (SIRS, presumed infection, discharged; n=27), and group 3 (SIRS, presumed noninfectious, admitted; n=45). Group 1 TNF-alpha and IL-6 levels were significantly higher than those found in the other groups. NO levels for groups 1 and 2 were significantly lower than those for group 3. TNF-alpha and IL-6 levels were higher in the group 1 subjects who had bacteremia or progressed to severe sepsis or death. NO levels were not associated with these outcomes.ED patients admitted with presumed sepsis have elevated cytokine levels compared with patients with sepsis who are discharged and with those patients with presumed noninfectious SIRS. An association appears to exist between cytokines and subsequent septic complications in these patients. The importance of these measures as clinical predictors for the presence of infection and subsequent septic complications needs to be evaluated.CONCLUSIONED patients admitted with presumed sepsis have elevated cytokine levels compared with patients with sepsis who are discharged and with those patients with presumed noninfectious SIRS. An association appears to exist between cytokines and subsequent septic complications in these patients. The importance of these measures as clinical predictors for the presence of infection and subsequent septic complications needs to be evaluated. |
| Author | Terregino, Carol A. Killian, Anthony J. Lopez, Bernard L. Arnold, Gerald K. Karras, David J. |
| Author_xml | – sequence: 1 givenname: Carol A. surname: Terregino fullname: Terregino, Carol A. organization: Department of Emergency Medicine, Cooper Hospital/University Medical Center, UMDNJ/Robert Wood Johnson Medical School, Camden, NJ – sequence: 2 givenname: Bernard L. surname: Lopez fullname: Lopez, Bernard L. organization: Department of Surgery, Division of Emergency Medicine, Thomas Jefferson University Hospital, Philadelphia, PA – sequence: 3 givenname: David J. surname: Karras fullname: Karras, David J. organization: Department of Medicine, Division of Emergency Medicine, Temple University Hospital, Philadelphia, PA – sequence: 4 givenname: Anthony J. surname: Killian fullname: Killian, Anthony J. organization: Department of Emergency Medicine, Cooper Hospital/University Medical Center, UMDNJ/Robert Wood Johnson Medical School, Camden, NJ – sequence: 5 givenname: Gerald K. surname: Arnold fullname: Arnold, Gerald K. organization: Department of Emergency Medicine, Cooper Hospital/University Medical Center, UMDNJ/Robert Wood Johnson Medical School, Camden, NJ |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1235233$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10613937$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkd1uEzEQhS1URNPCI4B8gRBcLNjrjZ0Foaqqyo9UiQvg2nK8s61h1956nKC8BM_MpAk_6k25Gmn8neOZOUfsIKYIjD2W4qUUUr_6LGSrK6Gb5rkQL4ygZqXvsZkUram00eKAzf4gh-wI8ZsQom1q-YAdSqGlapWZsZ_nsUuXENMK-QhdcCVl5CFyGCFT3294B5PLZYRY-ORKoIr8RyhXfMqAKxJxhAkDvuanGfgAaxiQO8TkyY1e92y6JBxDirwkUqyB4J2Qu9jRL65cnTxk93s3IDza12P29d35l7MP1cWn9x_PTi8q3xhVqqZTsp93eu5E19eglsbN-6ZRvVSgjTKLtu1MtxSN7utF72rttNdLs6iF7pURWh2zZztfmut6BVjsGNDDMLgIdAprxELqupEEPtmDqyWtaqccRpc39vcFCXi6Bxx6N_TZRR_wL1erea0UYfMd5nNCzND_42S3gdqbQO02LSuEvQnUbgd9c0vnQ6EUUizZheFO9clOTZHAOkC26ClAT0Fn8MV2Kdzp8PaWgx9CDLTpd9j8h_4XlNDPFA |
| CODEN | AEMED3 |
| CitedBy_id | crossref_primary_10_1016_S0163_7258_01_00155_3 crossref_primary_10_1111_j_1553_2712_2002_tb02143_x crossref_primary_10_1007_s00414_004_0481_0 crossref_primary_10_1155_2013_362793 crossref_primary_10_17116_hirurgia20151084_87 crossref_primary_10_3390_medicina59122054 crossref_primary_10_1157_13116751 crossref_primary_10_3748_wjg_v8_i1_131 crossref_primary_10_1186_cc2396 crossref_primary_10_3389_fimmu_2019_01427 crossref_primary_10_1016_j_cyto_2022_156006 crossref_primary_10_1203_PDR_0b013e3181559774 crossref_primary_10_1097_01_CCM_0000151049_19253_54 crossref_primary_10_1007_s00011_013_0661_9 crossref_primary_10_4049_jimmunol_177_3_1967 crossref_primary_10_1016_j_infect_2015_09_001 crossref_primary_10_1097_00000433_200209000_00018 crossref_primary_10_1097_01_shk_0000223120_26394_7d crossref_primary_10_1067_mem_2000_107670 crossref_primary_10_1002_cyto_b_20012 crossref_primary_10_1097_01_CCM_0000080492_81509_29 crossref_primary_10_1197_aemj_9_7_661 crossref_primary_10_18410_jebmh_2020_48 crossref_primary_10_1016_S0379_0738_00_00391_1 crossref_primary_10_1097_00024382_200206000_00004 crossref_primary_10_1002_jbt_23240 crossref_primary_10_1016_j_annemergmed_2006_05_003 crossref_primary_10_1038_sj_gt_3302441 crossref_primary_10_1016_S0025_7753_03_73955_4 crossref_primary_10_1111_j_1532_5415_2011_03823_x crossref_primary_10_1128_CDLI_8_6_1189_1195_2001 crossref_primary_10_1016_S0025_7753_03_73952_9 crossref_primary_10_1007_s11695_009_9851_5 crossref_primary_10_1016_S1081_1206_10_62923_7 crossref_primary_10_1016_S0733_8627_01_00010_4 crossref_primary_10_1053_joms_2001_25018 |
| Cites_doi | 10.1093/jnci/84.11.864 10.1097/00024382-199501000-00001 10.1016/S0140-6736(05)60602-2 10.1126/science.3764421 10.1097/00003246-199506000-00005 10.1097/00003246-199801000-00032 10.1016/S0140-6736(94)91584-9 10.1097/00003246-199611000-00001 10.1097/00003246-199703000-00006 10.1001/jama.1995.03520260039030 10.1097/00003246-199801000-00036 10.1128/IAI.60.6.2402-2408.1992 10.1093/infdis/168.4.955 10.1097/00003246-199407000-00009 10.1097/00003246-199512000-00002 10.1056/NEJM198806093182301 10.1097/00003246-199804000-00012 10.1093/infdis/172.1.296 10.1097/00003246-199611000-00003 10.1097/00003246-199706000-00027 10.1007/BF01708964 10.1056/NEJM199312303292706 10.1093/cvr/28.1.34 10.1097/00003246-199605000-00003 10.1097/00003246-199607000-00012 10.1378/chest.103.2.565 10.1097/00003246-199601000-00026 10.1097/00003246-199711000-00018 10.1016/S0022-3476(05)81753-6 10.1172/JCI113540 10.1111/j.1553-2712.1997.tb03760.x 10.1097/00003246-199711000-00014 10.1128/IAI.55.7.1622-1625.1987 10.1097/00000658-199111000-00013 10.1378/chest.101.6.1644 10.1093/jnci/82.9.772 10.1038/330662a0 10.1097/00003246-199502000-00009 10.1097/00003246-199702000-00029 10.1016/S0196-0644(05)80051-4 10.1148/radiology.148.3.6878708 10.1177/0310057X9202000303 10.1001/jama.1994.03510470040032 10.1097/00024382-199412000-00002 10.7326/0003-4819-119-8-199310150-00001 |
| ContentType | Journal Article |
| Copyright | 2000 American College of Emergency Physicians 2000 INIST-CNRS |
| Copyright_xml | – notice: 2000 American College of Emergency Physicians – notice: 2000 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/S0196-0644(00)70101-6 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-6760 |
| EndPage | 34 |
| ExternalDocumentID | 10613937 1235233 10_1016_S0196_0644_00_70101_6 S0196064400701016 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1RT 1~. 1~5 23M 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8F7 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKAS AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBLC ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADZCM AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AIVDX AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG COF CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDV HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM LX1 M27 M41 MO0 N4W N9A O-L O9- OAUVE OBH OB~ ODZKP OGIMB OHH OM0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSZ T5K TEORI UGJ UHS UKR UQY UV1 WOW YFH YOC Z5R ZGI ZXP ZY1 ~G- ~HD AACTN AAIAV AAYOK ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW LCYCR RIG ZA5 AAYXX CITATION AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c473t-4d31f5d65a0df2e3b7a5f443f13e6737899d7db046f28fa26a6c6b78206f37063 |
| IEDL.DBID | AIKHN |
| ISSN | 0196-0644 |
| IngestDate | Sun Sep 28 03:02:34 EDT 2025 Wed Feb 19 02:36:40 EST 2025 Mon Jul 21 09:15:18 EDT 2025 Thu Apr 24 23:08:41 EDT 2025 Wed Oct 01 04:51:28 EDT 2025 Fri Feb 23 02:30:53 EST 2024 Tue Oct 14 19:38:47 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Human Pathophysiology Mortality Cytokine Blood plasma Infection Interleukin 6 Sepsis syndrome Nitric oxide Adult Evolution Elderly Comparative study Tumor necrosis factor α |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c473t-4d31f5d65a0df2e3b7a5f443f13e6737899d7db046f28fa26a6c6b78206f37063 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 10613937 |
| PQID | 70816241 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_70816241 pubmed_primary_10613937 pascalfrancis_primary_1235233 crossref_primary_10_1016_S0196_0644_00_70101_6 crossref_citationtrail_10_1016_S0196_0644_00_70101_6 elsevier_sciencedirect_doi_10_1016_S0196_0644_00_70101_6 elsevier_clinicalkey_doi_10_1016_S0196_0644_00_70101_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2000 2000-1-00 2000-Jan 20000101 |
| PublicationDateYYYYMMDD | 2000-01-01 |
| PublicationDate_xml | – year: 2000 text: 2000 |
| PublicationDecade | 2000 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States |
| PublicationTitle | Annals of emergency medicine |
| PublicationTitleAlternate | Ann Emerg Med |
| PublicationYear | 2000 |
| Publisher | Mosby, Inc Elsevier |
| Publisher_xml | – name: Mosby, Inc – name: Elsevier |
| References | Terregino, Quinn, Slotman (bib20) 1997; 4 Martin, Saux, Mege (bib10) 1994; 20 Damas, Canivet, DeGroote (bib13) 1997; 25 Reinhart, Wiegand-Lohnert, Grimminger (bib39) 1996; 24 Gennari, Alexander (bib31) 1995; 23 Doughty, Carcillo, Kaplan (bib35) 1998; 26 Lowenstein, Dinerman, Snyder (bib33) 1994; 120 Tracey, Fong, Hesse (bib29) 1987; 330 Abraham, Anzueto, Gutierrez (bib38) 1998; 351 Bone, Balk, Cerra (bib1) 1992; 101 Ochoa, Udekwu, Billiar (bib19) 1991; 214 Barthlen, Stadler, Lehn (bib42) 1994; 2 van der Poll, Janse, van Leenen (bib48) 1993; 168 Mathison, Wolfson, Ulevitch (bib6) 1988; 81 Ochoa, Curti, Peitzman (bib7) 1992; 84 Pinsky, Vincent, Deviere (bib11) 1993; 103 Evans, Carpenter, Kinderman, Cohen (bib18) 1993; 41 van der Poll, Lowry (bib28) 1995; 1 Rangel-Frausto, Pittet, Costigan (bib43) 1995; 273 Michie, Manogue, Spriggs (bib30) 1988; 318 Muckart, Bhagwanjee (bib46) 1997; 25 Livingston, Mosenthal, Deitch (bib2) 1995; 3 Friedland, Suputtamongkol, Remick (bib14) 1992; 60 Moscovitz, Shofer, Mignott (bib21) 1994; 22 Marchant, Deviere, Byl (bib27) 1994; 343 Gardlund, Sjolin, Nilsson (bib15) 1995; 172 Martin, Boisson, Haccoun (bib12) 1997; 25 Bellomo (bib25) 1992; 20 Matuschak (bib47) 1996; 24 Tracey, Beutler, Lowry (bib4) 1986; 234 Saladino, Erikson, Levy, Bachman, Silber, Fleisher (bib22) 1992; 21 Avontuur, Nolthenius, van Bodegom (bib41) 1998; 26 Kilbourn, Fonseca, Friggith (bib9) 1995; 23 Doughty, Kaplan, Carcillo (bib26) 1996; 24 Friedland, Porter, Daryanani (bib16) 1996; 24 Moncada, Higgs (bib32) 1993; 329 Casey, Balk, Bone (bib3) 1993; 119 Hanley, McNeil (bib24) 1983; 148 Petros, Lamb, Leone (bib40) 1994; 28 Bauss, Droge, Mannel (bib5) 1987; 55 Gómez-Jiménez, Salgado, Mourelle (bib17) 1995; 23 Kilbourn, Belloni (bib8) 1990; 82 Dellinger, Bone (bib45) 1998; 26 Spack, Havens, Griffith (bib34) 1997; 25 Shi, Li, Shen (bib36) 1993; 123 Vincent (bib44) 1997; 25 Bone (bib23) 1996; 24 Fisher, Dhainaut, Opal (bib37) 1994; 271 Dellinger (10.1016/S0196-0644(00)70101-6_bib45) 1998; 26 Bauss (10.1016/S0196-0644(00)70101-6_bib5) 1987; 55 Pinsky (10.1016/S0196-0644(00)70101-6_bib11) 1993; 103 Friedland (10.1016/S0196-0644(00)70101-6_bib14) 1992; 60 Doughty (10.1016/S0196-0644(00)70101-6_bib26) 1996; 24 Mathison (10.1016/S0196-0644(00)70101-6_bib6) 1988; 81 Bone (10.1016/S0196-0644(00)70101-6_bib1) 1992; 101 Ochoa (10.1016/S0196-0644(00)70101-6_bib7) 1992; 84 Damas (10.1016/S0196-0644(00)70101-6_bib13) 1997; 25 Fisher (10.1016/S0196-0644(00)70101-6_bib37) 1994; 271 Tracey (10.1016/S0196-0644(00)70101-6_bib29) 1987; 330 Hanley (10.1016/S0196-0644(00)70101-6_bib24) 1983; 148 Moscovitz (10.1016/S0196-0644(00)70101-6_bib21) 1994; 22 Michie (10.1016/S0196-0644(00)70101-6_bib30) 1988; 318 Terregino (10.1016/S0196-0644(00)70101-6_bib20) 1997; 4 Rangel-Frausto (10.1016/S0196-0644(00)70101-6_bib43) 1995; 273 Livingston (10.1016/S0196-0644(00)70101-6_bib2) 1995; 3 Muckart (10.1016/S0196-0644(00)70101-6_bib46) 1997; 25 van der Poll (10.1016/S0196-0644(00)70101-6_bib28) 1995; 1 Martin (10.1016/S0196-0644(00)70101-6_bib12) 1997; 25 Friedland (10.1016/S0196-0644(00)70101-6_bib16) 1996; 24 Martin (10.1016/S0196-0644(00)70101-6_bib10) 1994; 20 Marchant (10.1016/S0196-0644(00)70101-6_bib27) 1994; 343 Moncada (10.1016/S0196-0644(00)70101-6_bib32) 1993; 329 Avontuur (10.1016/S0196-0644(00)70101-6_bib41) 1998; 26 Lowenstein (10.1016/S0196-0644(00)70101-6_bib33) 1994; 120 Doughty (10.1016/S0196-0644(00)70101-6_bib35) 1998; 26 Kilbourn (10.1016/S0196-0644(00)70101-6_bib8) 1990; 82 Gennari (10.1016/S0196-0644(00)70101-6_bib31) 1995; 23 Shi (10.1016/S0196-0644(00)70101-6_bib36) 1993; 123 Bone (10.1016/S0196-0644(00)70101-6_bib23) 1996; 24 Matuschak (10.1016/S0196-0644(00)70101-6_bib47) 1996; 24 Kilbourn (10.1016/S0196-0644(00)70101-6_bib9) 1995; 23 Casey (10.1016/S0196-0644(00)70101-6_bib3) 1993; 119 Reinhart (10.1016/S0196-0644(00)70101-6_bib39) 1996; 24 Gardlund (10.1016/S0196-0644(00)70101-6_bib15) 1995; 172 Ochoa (10.1016/S0196-0644(00)70101-6_bib19) 1991; 214 Spack (10.1016/S0196-0644(00)70101-6_bib34) 1997; 25 Vincent (10.1016/S0196-0644(00)70101-6_bib44) 1997; 25 Barthlen (10.1016/S0196-0644(00)70101-6_bib42) 1994; 2 Bellomo (10.1016/S0196-0644(00)70101-6_bib25) 1992; 20 Abraham (10.1016/S0196-0644(00)70101-6_bib38) 1998; 351 Tracey (10.1016/S0196-0644(00)70101-6_bib4) 1986; 234 van der Poll (10.1016/S0196-0644(00)70101-6_bib48) 1993; 168 Evans (10.1016/S0196-0644(00)70101-6_bib18) 1993; 41 Saladino (10.1016/S0196-0644(00)70101-6_bib22) 1992; 21 Petros (10.1016/S0196-0644(00)70101-6_bib40) 1994; 28 Gómez-Jiménez (10.1016/S0196-0644(00)70101-6_bib17) 1995; 23 10874248 - Ann Emerg Med. 2000 Jul;36(1):80-1 |
| References_xml | – volume: 25 start-page: 1789 year: 1997 end-page: 1794 ident: bib46 article-title: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients – volume: 23 start-page: 253 year: 1995 end-page: 258 ident: bib17 article-title: L-arginine: nitric oxide pathway in endotoxemia and human septic shock – volume: 24 start-page: 163 year: 1996 end-page: 172 ident: bib23 article-title: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation – volume: 81 start-page: 1925 year: 1988 end-page: 1937 ident: bib6 article-title: Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits – volume: 214 start-page: 621 year: 1991 end-page: 626 ident: bib19 article-title: Nitrogen oxide levels in patients after trauma and during sepsis – volume: 24 start-page: 733 year: 1996 end-page: 742 ident: bib39 article-title: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study – volume: 84 start-page: 864 year: 1992 end-page: 867 ident: bib7 article-title: Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes – volume: 343 start-page: 707 year: 1994 end-page: 708 ident: bib27 article-title: Interleukin-10 production during septicaemia – volume: 101 start-page: 1644 year: 1992 end-page: 1662 ident: bib1 article-title: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference – volume: 148 start-page: 839 year: 1983 end-page: 843 ident: bib24 article-title: A method of comparing the areas under receiver operating characteristic curves derived from the same cases – volume: 20 start-page: 288 year: 1992 end-page: 301 ident: bib25 article-title: The cytokine network in the critically ill – volume: 25 start-page: 405 year: 1997 end-page: 412 ident: bib13 article-title: Sepsis and serum cytokine concentrations – volume: 25 start-page: 1813 year: 1997 end-page: 1819 ident: bib12 article-title: Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma – volume: 172 start-page: 296 year: 1995 end-page: 301 ident: bib15 article-title: Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity – volume: 25 start-page: 1071 year: 1997 end-page: 1078 ident: bib34 article-title: Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome – volume: 26 start-page: 178 year: 1998 end-page: 179 ident: bib45 article-title: To SIRS with love – volume: 23 start-page: 1018 year: 1995 end-page: 1024 ident: bib9 article-title: NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension – volume: 330 start-page: 662 year: 1987 end-page: 664 ident: bib29 article-title: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia – volume: 55 start-page: 1622 year: 1987 end-page: 1625 ident: bib5 article-title: Tumor necrosis factor mediates endotoxic effects in mice – volume: 351 start-page: 929 year: 1998 end-page: 933 ident: bib38 article-title: Double-blind randomized controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock – volume: 3 start-page: 257 year: 1995 end-page: 266 ident: bib2 article-title: Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview – volume: 120 start-page: 227 year: 1994 end-page: 237 ident: bib33 article-title: Nitric oxide: a physiologic messenger – volume: 26 start-page: 660 year: 1998 end-page: 667 ident: bib41 article-title: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study – volume: 20 start-page: 272 year: 1994 end-page: 277 ident: bib10 article-title: Prognostic values of serum cytokines in septic shock – volume: 1 start-page: 1 year: 1995 end-page: 12 ident: bib28 article-title: Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? – volume: 21 start-page: 1413 year: 1992 end-page: 1417 ident: bib22 article-title: Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children – volume: 26 start-page: 157 year: 1998 end-page: 162 ident: bib35 article-title: Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis – volume: 25 start-page: 372 year: 1997 end-page: 374 ident: bib44 article-title: Dear SIRS, I’m sorry to say that I don’t like you… – volume: 318 start-page: 1481 year: 1988 end-page: 1486 ident: bib30 article-title: Detection of circulating tumor necrosis factor after endotoxin administration – volume: 41 start-page: 77 year: 1993 end-page: 81 ident: bib18 article-title: Evidence of increased nitric oxide production in patients with the sepsis syndrome – volume: 123 start-page: 435 year: 1993 end-page: 438 ident: bib36 article-title: Plasma nitric oxide levels in newborn infants with sepsis – volume: 103 start-page: 565 year: 1993 end-page: 575 ident: bib11 article-title: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality – volume: 234 start-page: 470 year: 1986 end-page: 474 ident: bib4 article-title: Shock and tissue injury induced by recombinant human cachectin – volume: 22 start-page: 1102 year: 1994 end-page: 1107 ident: bib21 article-title: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity – volume: 28 start-page: 34 year: 1994 end-page: 39 ident: bib40 article-title: Effects of a nitric oxide synthase inhibitor in humans with septic shock – volume: 23 start-page: 1945 year: 1995 end-page: 1953 ident: bib31 article-title: Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense – volume: 168 start-page: 955 year: 1993 end-page: 960 ident: bib48 article-title: Release of soluble receptor for tumor necrosis factor in clinical sepsis and experimental endotoxemia – volume: 329 start-page: 2002 year: 1993 end-page: 2012 ident: bib32 article-title: The L-arginine-nitric oxide pathway. Mechanisms of disease – volume: 4 start-page: 684 year: 1997 end-page: 688 ident: bib20 article-title: Pilot study of cytokines in emergency department patients with systemic inflammatory response syndrome – volume: 60 start-page: 2402 year: 1992 end-page: 2408 ident: bib14 article-title: Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized – volume: 82 start-page: 772 year: 1990 end-page: 776 ident: bib8 article-title: Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin – volume: 24 start-page: 1775 year: 1996 end-page: 1781 ident: bib16 article-title: Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit – volume: 24 start-page: 1769 year: 1996 end-page: 1771 ident: bib47 article-title: Circulating cytokine concentrations and outcome prediction in intensive care unit patients: still the tip of the iceberg? – volume: 2 start-page: 398 year: 1994 end-page: 401 ident: bib42 article-title: Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor α and negatively with body temperature in patients with postoperative abdominal sepsis – volume: 24 start-page: 1137 year: 1996 end-page: 1143 ident: bib26 article-title: Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure – volume: 119 start-page: 771 year: 1993 end-page: 778 ident: bib3 article-title: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome – volume: 271 start-page: 1836 year: 1994 end-page: 1844 ident: bib37 article-title: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial – volume: 273 start-page: 117 year: 1995 end-page: 123 ident: bib43 article-title: The natural history of the systemic inflammatory response syndrome (SIRS) – volume: 84 start-page: 864 year: 1992 ident: 10.1016/S0196-0644(00)70101-6_bib7 article-title: Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes publication-title: J Natl Cancer Inst doi: 10.1093/jnci/84.11.864 – volume: 1 start-page: 1 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib28 article-title: Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? publication-title: Shock doi: 10.1097/00024382-199501000-00001 – volume: 351 start-page: 929 year: 1998 ident: 10.1016/S0196-0644(00)70101-6_bib38 article-title: Double-blind randomized controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock publication-title: Lancet doi: 10.1016/S0140-6736(05)60602-2 – volume: 234 start-page: 470 year: 1986 ident: 10.1016/S0196-0644(00)70101-6_bib4 article-title: Shock and tissue injury induced by recombinant human cachectin publication-title: Science doi: 10.1126/science.3764421 – volume: 23 start-page: 1018 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib9 article-title: NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension publication-title: Crit Care Med doi: 10.1097/00003246-199506000-00005 – volume: 26 start-page: 157 year: 1998 ident: 10.1016/S0196-0644(00)70101-6_bib35 article-title: Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis publication-title: Crit Care Med doi: 10.1097/00003246-199801000-00032 – volume: 343 start-page: 707 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib27 article-title: Interleukin-10 production during septicaemia publication-title: Lancet doi: 10.1016/S0140-6736(94)91584-9 – volume: 24 start-page: 1769 year: 1996 ident: 10.1016/S0196-0644(00)70101-6_bib47 article-title: Circulating cytokine concentrations and outcome prediction in intensive care unit patients: still the tip of the iceberg? publication-title: Crit Care Med doi: 10.1097/00003246-199611000-00001 – volume: 25 start-page: 405 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib13 article-title: Sepsis and serum cytokine concentrations publication-title: Crit Care Med doi: 10.1097/00003246-199703000-00006 – volume: 273 start-page: 117 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib43 article-title: The natural history of the systemic inflammatory response syndrome (SIRS) publication-title: JAMA doi: 10.1001/jama.1995.03520260039030 – volume: 26 start-page: 178 year: 1998 ident: 10.1016/S0196-0644(00)70101-6_bib45 article-title: To SIRS with love publication-title: Crit Care Med doi: 10.1097/00003246-199801000-00036 – volume: 60 start-page: 2402 year: 1992 ident: 10.1016/S0196-0644(00)70101-6_bib14 article-title: Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection publication-title: Infect Immun doi: 10.1128/IAI.60.6.2402-2408.1992 – volume: 168 start-page: 955 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib48 article-title: Release of soluble receptor for tumor necrosis factor in clinical sepsis and experimental endotoxemia publication-title: J Infect Dis doi: 10.1093/infdis/168.4.955 – volume: 22 start-page: 1102 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib21 article-title: Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity publication-title: Crit Care Med doi: 10.1097/00003246-199407000-00009 – volume: 23 start-page: 1945 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib31 article-title: Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense publication-title: Crit Care Med doi: 10.1097/00003246-199512000-00002 – volume: 120 start-page: 227 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib33 article-title: Nitric oxide: a physiologic messenger publication-title: Ann Emerg Med – volume: 318 start-page: 1481 year: 1988 ident: 10.1016/S0196-0644(00)70101-6_bib30 article-title: Detection of circulating tumor necrosis factor after endotoxin administration publication-title: N Engl J Med doi: 10.1056/NEJM198806093182301 – volume: 26 start-page: 660 year: 1998 ident: 10.1016/S0196-0644(00)70101-6_bib41 article-title: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study publication-title: Crit Care Med doi: 10.1097/00003246-199804000-00012 – volume: 172 start-page: 296 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib15 article-title: Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity publication-title: J Infect Dis doi: 10.1093/infdis/172.1.296 – volume: 24 start-page: 1775 year: 1996 ident: 10.1016/S0196-0644(00)70101-6_bib16 article-title: Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit publication-title: Crit Care Med doi: 10.1097/00003246-199611000-00003 – volume: 25 start-page: 1071 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib34 article-title: Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome publication-title: Crit Care Med doi: 10.1097/00003246-199706000-00027 – volume: 20 start-page: 272 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib10 article-title: Prognostic values of serum cytokines in septic shock publication-title: Intensive Care Med doi: 10.1007/BF01708964 – volume: 329 start-page: 2002 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib32 article-title: The L-arginine-nitric oxide pathway. Mechanisms of disease publication-title: N Engl J Med doi: 10.1056/NEJM199312303292706 – volume: 28 start-page: 34 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib40 article-title: Effects of a nitric oxide synthase inhibitor in humans with septic shock publication-title: Cardiovasc Res doi: 10.1093/cvr/28.1.34 – volume: 24 start-page: 733 year: 1996 ident: 10.1016/S0196-0644(00)70101-6_bib39 article-title: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study publication-title: Crit Care Med doi: 10.1097/00003246-199605000-00003 – volume: 24 start-page: 1137 year: 1996 ident: 10.1016/S0196-0644(00)70101-6_bib26 article-title: Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure publication-title: Crit Care Med doi: 10.1097/00003246-199607000-00012 – volume: 103 start-page: 565 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib11 article-title: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality publication-title: Chest doi: 10.1378/chest.103.2.565 – volume: 24 start-page: 163 year: 1996 ident: 10.1016/S0196-0644(00)70101-6_bib23 article-title: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation publication-title: Crit Care Med doi: 10.1097/00003246-199601000-00026 – volume: 25 start-page: 1813 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib12 article-title: Patterns of cytokine evolution (tumor necrosis factor-α and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma publication-title: Crit Care Med doi: 10.1097/00003246-199711000-00018 – volume: 123 start-page: 435 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib36 article-title: Plasma nitric oxide levels in newborn infants with sepsis publication-title: J Pediatr doi: 10.1016/S0022-3476(05)81753-6 – volume: 81 start-page: 1925 year: 1988 ident: 10.1016/S0196-0644(00)70101-6_bib6 article-title: Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits publication-title: J Clin Invest doi: 10.1172/JCI113540 – volume: 4 start-page: 684 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib20 article-title: Pilot study of cytokines in emergency department patients with systemic inflammatory response syndrome publication-title: Acad Emerg Med doi: 10.1111/j.1553-2712.1997.tb03760.x – volume: 25 start-page: 1789 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib46 article-title: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients publication-title: Crit Care Med doi: 10.1097/00003246-199711000-00014 – volume: 55 start-page: 1622 year: 1987 ident: 10.1016/S0196-0644(00)70101-6_bib5 article-title: Tumor necrosis factor mediates endotoxic effects in mice publication-title: Infect Immun doi: 10.1128/IAI.55.7.1622-1625.1987 – volume: 214 start-page: 621 year: 1991 ident: 10.1016/S0196-0644(00)70101-6_bib19 article-title: Nitrogen oxide levels in patients after trauma and during sepsis publication-title: Ann Surg doi: 10.1097/00000658-199111000-00013 – volume: 101 start-page: 1644 year: 1992 ident: 10.1016/S0196-0644(00)70101-6_bib1 article-title: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference publication-title: Chest doi: 10.1378/chest.101.6.1644 – volume: 3 start-page: 257 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib2 article-title: Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview publication-title: New Horizons – volume: 82 start-page: 772 year: 1990 ident: 10.1016/S0196-0644(00)70101-6_bib8 article-title: Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin publication-title: J Natl Cancer Inst doi: 10.1093/jnci/82.9.772 – volume: 330 start-page: 662 year: 1987 ident: 10.1016/S0196-0644(00)70101-6_bib29 article-title: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia publication-title: Nature doi: 10.1038/330662a0 – volume: 23 start-page: 253 year: 1995 ident: 10.1016/S0196-0644(00)70101-6_bib17 article-title: L-arginine: nitric oxide pathway in endotoxemia and human septic shock publication-title: Crit Care Med doi: 10.1097/00003246-199502000-00009 – volume: 25 start-page: 372 year: 1997 ident: 10.1016/S0196-0644(00)70101-6_bib44 article-title: Dear SIRS, I’m sorry to say that I don’t like you… publication-title: Crit Care Med doi: 10.1097/00003246-199702000-00029 – volume: 21 start-page: 1413 year: 1992 ident: 10.1016/S0196-0644(00)70101-6_bib22 article-title: Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children publication-title: Ann Emerg Med doi: 10.1016/S0196-0644(05)80051-4 – volume: 148 start-page: 839 year: 1983 ident: 10.1016/S0196-0644(00)70101-6_bib24 article-title: A method of comparing the areas under receiver operating characteristic curves derived from the same cases publication-title: Radiology doi: 10.1148/radiology.148.3.6878708 – volume: 41 start-page: 77 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib18 article-title: Evidence of increased nitric oxide production in patients with the sepsis syndrome publication-title: Circ Shock – volume: 20 start-page: 288 year: 1992 ident: 10.1016/S0196-0644(00)70101-6_bib25 article-title: The cytokine network in the critically ill publication-title: Anaesth Intensive Care doi: 10.1177/0310057X9202000303 – volume: 271 start-page: 1836 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib37 article-title: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial publication-title: JAMA doi: 10.1001/jama.1994.03510470040032 – volume: 2 start-page: 398 year: 1994 ident: 10.1016/S0196-0644(00)70101-6_bib42 article-title: Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor α and negatively with body temperature in patients with postoperative abdominal sepsis publication-title: Shock doi: 10.1097/00024382-199412000-00002 – volume: 119 start-page: 771 year: 1993 ident: 10.1016/S0196-0644(00)70101-6_bib3 article-title: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome publication-title: Ann Intern Med doi: 10.7326/0003-4819-119-8-199310150-00001 – reference: 10874248 - Ann Emerg Med. 2000 Jul;36(1):80-1 |
| SSID | ssj0009421 |
| Score | 1.811043 |
| Snippet | Study Objective: We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-α, interleukin (IL) 6, and nitric oxide (NO)... We sought to determine whether levels of the endogenous mediators tumor necrosis factor (TNF)-alpha, interleukin (IL) 6, and nitric oxide (NO) measured in... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 26 |
| SubjectTerms | Adult Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Biomarkers - blood Disease Progression Emergency and intensive care: infection, septic shock Emergency Treatment Female Hospitalization - statistics & numerical data Humans Intensive care medicine Interleukin-6 - blood Male Medical sciences Middle Aged Nitric Oxide - blood Prognosis Prospective Studies Reproducibility of Results ROC Curve Severity of Illness Index Systemic Inflammatory Response Syndrome - blood Systemic Inflammatory Response Syndrome - complications Systemic Inflammatory Response Syndrome - immunology Systemic Inflammatory Response Syndrome - microbiology Systemic Inflammatory Response Syndrome - mortality Tumor Necrosis Factor-alpha - metabolism |
| Title | Endogenous mediators in emergency department patients with presumed sepsis: Are levels associated with progression to severe sepsis and death? |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0196064400701016 https://dx.doi.org/10.1016/S0196-0644(00)70101-6 https://www.ncbi.nlm.nih.gov/pubmed/10613937 https://www.proquest.com/docview/70816241 |
| Volume | 35 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1097-6760 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009421 issn: 0196-0644 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1097-6760 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009421 issn: 0196-0644 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1097-6760 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009421 issn: 0196-0644 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1097-6760 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009421 issn: 0196-0644 databaseCode: AKRWK dateStart: 19800101 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61WwkhIcSbBVp84ACHdOP4kYQLqqpWC6i9QKXerElsVytV2VWzXPkJ_GbGsdNtD1UR1yTjOPZ45rMz8w3AB2xlja3IM_RYZbJ2dYZN02S6IiRXcmkdD_nOJ6d6fia_navzLTgcc2FCWGWy_dGmD9Y6XZml0ZytFovZj8DsQg41FPYeiNK2YYf8T1VNYOfg6_f56YZ7VxapLCFtnklgk8gTGxkufszzT0M7mb7LRT1aYU8D52PFi7sh6eCajp_A44Qp2UHs9lPYct0zeHCS_po_hz9HnV1GMlY2ZIqECjts0TE35l4yS17pagg4Z4lptWfhiJaFOFkyX5b1btUv-s_0FscuQ6RRzzBNLd1Nzy4vYlhtx9ZLkqBl4pIgw87SWwhvfnkBZ8dHPw_nWarDkLWyFOtMWsG9slphbn3hRFOi8lIKz4ULZW5oy2ZL29BO2xeVx0KjbnUTiPi0FyVhoJcw6Zadew3Mo1clb5V2tZZWcSywaEWtUBFWcAWfghyH3rSJpDzUyrg0N6LRam3CjJk8N8OMGT2F_WuxVWTpuE9Aj_NqxhRUMpqG_Mh9gtW14C09_RfR3VsKtOlpQShYiCm8HxXK0BoPP26wc6Qa1EDFNUGtKbyKenbjIwmOEcJ88__degsPI71AOFZ6B5P11S-3S0Br3ezB9v5vvpeW019SNiGW |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKrWVKgT0taUUHzi0h7CJX0l6qSoE2haWS0HiZjmxXa2EsiuyvfYn9Dd3_AgLB0TF1fHYjj2e-WzPA2Bft7zWLcsz7XSV8drWmW6aJpMVIrmy4MYW3t95eiYnF_zHpbhcg8PBF8abVSbZH2V6kNapZJxmc7yYzcY_fWQXVKg-sXcIlPYEnnJBS38CO_izsvOoOU1JCfHojNVXbjyxiVD4Kc8_h1YyeZ-CernQPU6bi_ku7gekQTEdb8JGQpTkWxz0FqzZbhueTdOb-Sv4e9SZeQzFSoKfiM-vQ2YdsYPnJTGok66DuTlJcVZ74i9oibeSReFlSG8X_az_gr1YcuXtjHqi08Li11R3_isa1XZkOUcK3CQ2ERLdGewF0ebX13BxfHR-OMlSFoas5SVbZtywwgkjhc6No5Y1pRaOc-YKZn2SGzywmdI0eM52tHKaSi1b2fgwfNKxEhHQG1jv5p19B8RpJ8qiFdLWkhtRaKppy2qhBSIFS4sR8GHqVZtClPtMGVfqli1aLZVfMZXnKqyYkiM4uCFbxBgdDxHIYV3V4ICKIlOhFnmIsLohvMOl_0O6e4eBViOliIEZG8HewFAKd7h_ttGdRdbABqpCItAawdvIZ7d-EsEY4sv3jx_WHjyfnE9P1en3s5MdeBEDDfgLpg-wvrz-bXcRci2bj2FL_QO2OCJe |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endogenous+mediators+in+emergency+department+patients+with+presumed+sepsis%3A+Are+levels+associated+with+progression+to+severe+sepsis+and+death%3F&rft.jtitle=Annals+of+emergency+medicine&rft.au=Terregino%2C+Carol+A.&rft.au=Lopez%2C+Bernard+L.&rft.au=Karras%2C+David+J.&rft.au=Killian%2C+Anthony+J.&rft.date=2000&rft.pub=Mosby%2C+Inc&rft.issn=0196-0644&rft.volume=35&rft.issue=1&rft.spage=26&rft.epage=34&rft_id=info:doi/10.1016%2FS0196-0644%2800%2970101-6&rft.externalDocID=S0196064400701016 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0196-0644&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0196-0644&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0196-0644&client=summon |